Lithium enhances secretion from large dense-core vesicles in nerve growth factor-differentiated PC12 cells

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Lithium (Li) is a key therapeutic agent for bipolar disorders, though its precise neuronal mechanisms remain unclear.
• Previous studies show Li modulates proteins within large dense-core vesicles (LDCVs), which store and release neurotransmitters.
• This study investigates how Li affects LDCV properties and secretion in neuronal models.

Purpose of the Study:

• To determine the impact of lithium on the expression and secretion of LDCV cargo proteins.
• To examine how lithium influences LDCV characteristics, such as size and number.
• To understand the functional consequences of Li-induced changes on cellular secretion.

Main Methods:

• PC12 cells were treated with lithium.
• Immunoblotting was used to quantify LDCV cargo proteins (chromogranin B, secretogranin II).
• Amperometry measured cellular secretion, and electron microscopy analyzed LDCV morphology.

Main Results:

• Lithium treatment significantly increased cellular content and secretion of chromogranin B and secretogranin II.
• Amperometry showed an increased number of secretory spikes upon K+-depolarization, without altering spike amplitude or kinetics.
• Electron microscopy revealed a ~15% increase in LDCV diameter, but no change in LDCV number per area.

Conclusions:

• Lithium alters LDCV properties, specifically increasing their diameter.
• These changes lead to augmented regulated secretion in nerve growth factor-differentiated PC12 cells.
• Findings provide insights into Li-dependent cellular mechanisms potentially underlying its therapeutic efficacy in mood disorders.